Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium hyaluronate injections for temporomandibular joint dysfunction syndrome
RBR-6759yzPhase 3Completed
- Sponsor
- Universidade Federal de Minas Gerais
- Start
- Feb 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of sodium hyaluronate in temporomandibular disorder (TMD) and temporomandibular joint disc disorder, sponsored by Universidade Federal de Minas Gerais. Started Feb 2016; status: completed.
02
Drugs
sodium hyaluronate
03
Conditions
temporomandibular disorder (TMD)temporomandibular joint disc disorder
Beyond the preview
Go deeper on RBR-6759yz.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-6759yz.